Ghost Tree Capital »

Cytomx Therapeutics shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $366k 300k 1.22
2024-03-31 $1.3M 600k 2.18

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Cytomx Therapeutics

Tang Capital Management
Henderson Group
BVF
Vanguard Group
Acadian Asset Management
Assenagon Asset Management
Jacobs Levy Equity Management
Laurion Capital Management
Congress Park Capital
Schonfeld Strategic Advisors
BlackRock
Superstring Capital Management
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Cytomx Therapeutics